Presbyopia Clinical Trial
Official title:
PROductivity Study of Presbyopia Elimination in Rural-dwellers (PROSPER)
This trial seeks to establish, using a randomized, controlled design, the impact of near eyesight correction on the productivity of presbyopic agricultural workers in India, as measured by weight of tea picked.
Main research question being addressed: To establish, using a randomized, controlled design,
the impact of near eyesight correction on the productivity of presbyopic agricultural workers
in India, as measured by weight of tea picked.
Primary outcomes to be measured: Change in mean daily weight of tea picked per worker during
a 12 weeks period after randomisation compared to a 4 weeks baseline period prior to
randomisation. (See details below under Main Outcome.)
I. Background: Importance of research topic, Particular Features of setting Uncorrected
presbyopia is an expensive problem for the world. Lost productivity among adults who need
eyeglasses has been estimated to cost the global economy $227 billion every year, [1,2] and
illiteracy may lead to a further $3 trillion in annual global economic losses. It has been
shown that 74% of illiterate adults failed one or more parts of a vision screening. [3]
However, in order to motivate governments, industry and other key stakeholders to invest in
solving the problem of uncorrected near vision in adults, higher-quality data on the
productivity impact of correction are needed. Current studies are suggestive, but
carefully-performed randomized trials are still lacking in the published literature.
An unpublished University of Michigan (USA) working paper found that correcting near-vision
loss with glasses yields an increase in productivity of up to 34%, though no control group
was included, and the outcome assessed was not precisely defined. An unpublished impact
assessment conducted by Building Resources Across Communities (BRAC), the world's largest NGO
in the number of staff, concluded that 90% of individuals experiencing near-vision loss in
Bangladesh encountered problems with their daily work; and, on average, 23% reported that
their income was compromised.[4] In Rwanda, Lifetime Consulting & Partners found that workers
with poor vision who did not wear glasses were three times more likely to be asked by
supervisors to repeat their work of sorting coffee beans than after receiving and wearing
glasses.[4] Again, no control group was included, and this work has not been published.
Furthermore, a Dalberg Global Development Advisors study of adults in India who had their
vision corrected with glasses found that 65% reported an increase in independence in movement
and travel, and 59% reported improved work productivity, [5] but these outcomes were not
confirmed quantitatively or objectively. Finally, a population study of 1008 older adults in
Shenyang, northern China, found that those with uncorrected presbyopia (69%) were more likely
to report diminished accomplishment due to vision (P = 0.01, adjusted for age, sex,
education, and distance vision) than were those without presbyopia. [6] The impact of
correcting presbyopia was not studied in a prospective fashion.
In summary, available data are consistent with the idea that correcting presbyopia can lead
to significant improvements in productivity among adult workers. However, in the absence of
high-quality randomized trials, it is very difficult to be certain about cause and effect: it
is equally plausible that the economic burden of poverty could result in failure to purchase
glasses, rather than the reverse. Lack of control groups and carefully-defined productivity
outcomes in many studies further hinder interpretation. Policy makers and industry partners
require more convincing data in order to commit to the support of programs of vision
correction.
Features of this setting:
A high proportion (> 50%) of workers have presbyopia in this large workforce, and previous
projects by Vision Spring have shown that the large majority of these workers have no
presbyopic correction.
The primary outcome (daily weight of tea picked) is measured and recorded by Amalgamated Tea
as part of routine practice.
The work population is very stable, and data from previous years have been used for sample
size calculations.
The project will be carried out during the high season (July through October) when the amount
of tea picked is limited by the labourer and not by the growth of the plants. Further, these
agricultural workers are strongly incentivized to pick more tea, because they are paid by
weight, and thus gain in income when their personal productivity increases.
II. Experimental plan
Study design: Randomized, investigator-masked controlled trial
Methods to be used:
Population: Presbyopic (generally age >= 40 years) tea workers at the Amalgamated Plantations
Pvt Ltd (APPL) in Assam, India.
Baseline data acquisition: Demographic and clinical: Age, sex, contact information, habitual
and best-corrected visual acuity at near and distance; power of distance and near refractive
error in each eye; workers with acuity not improving to 6/7.5 in either eye at distance will
undergo dilated fundus examination and will be referred to a local collaborating facility for
care if needed. Work productivity: Daily mean weight of tea picked during a 4 weeks baseline
period prior to randomisation.
Recruitment and consent: Approximately 1500 APPL workers aged 40 years or more will undergo
assessment of above clinical criteria ("Baseline data acquisition") by VisionSpring local
staff, assisted by APPL as part of the on-going Clear Vision Workplace program. Those meeting
inclusion criteria (see below) will be invited to join to the study and complete informed
consent forms. Recruitment will continue until approximately 700 persons have joined the
study (see sample size calculations below). Baseline work productivity will be measured as
outlined above for a 4-week period).
Randomization, Balancing, and Intervention: Eligible workers completing baseline productivity
assessment will be enrolled into the study, and assigned at random to one of the below
groups:
Intervention Group: Will immediately receive a free pair of presbyopic glasses through the
Clear Vision Workplace program. These glasses will correct the worker's vision at their own
usual working distance (methodology described in the full protocol), and will not correct
astigmatism. Distance refractive errors will be corrected for those with uncorrected VA <
6/12 in the better-seeing eye, but such persons will be excluded from the trial.
Control Group: Will be deferred to receive free presbyopic spectacles after the 12 weeks
evaluation period.
Balance of the groups on age and baseline work productivity, will be assessed and maintained
insofar as possible, and allocation concealment prior to randomisation will be ensured
through the use of a secure process so that neither the participant nor the person recruiting
them to the study will know in advance whether or not they will receive spectacles
immediately or after 12 weeks.
Randomization methodology: Eligible workers completing baseline data collection will be
enrolled into the study, and stratified into eight groups according to age (<50, >=50), sex
and baseline work productivity (<median, >=median), then participants among each of the eight
groups will be assigned at random to one of the study arms.
An independent statistician having no contact with participants will generate the
randomization sequence using a computer system that is inaccessible until after recruitment.
The participants in each stratified group will be assigned to either the intervention or
control group in a 1:1 ratio with the block size of six. The participants will know their
group assignment. However, the APPL staff measuring the weight and quality outcomes will be
masked to a worker's group assignment by having an intermediate person receive the tea from
the worker at the weighing station each day.
Main outcome and masking: The daily mean weight of tea picked will be calculated for each
worker for the 4 weeks baseline and for the 12 weeks evaluation period. The difference
between these two means will be calculated for each worker, and the mean of this value will
be calculated for each randomised group, with the main study outcome being the difference
between these values for each group. It will not be practical to mask participants to their
study group assignment (the investigators do not feel that providing sham near correction of
Plano power is ethical). However, the APPL staff measuring the weight outcomes will be masked
to a worker's group assignment by having an intermediate person receive the tea from the
worker and carry it to the weighing station each day. Secondary outcomes will include visual
quality of life in both groups, self-reported wear of the study spectacles in the
intervention group, self-reported purchase and use of glasses in the control group,
independent compliance observations, quality of tea picked (if possible to assess) and the
proportion of workers who work than less than 10 days in a month during the 12 weeks
evaluation period.
Study hypothesis: Productivity gains in the Intervention Group will be significantly greater
than those in the Control Group when the 12 weeks evaluation period is compared to the 4
weeks baseline period.
Sample size calculations: With two-sided significance level of P=0.05, power of 80%, a daily
mean of 25.0 (SD: 5.0) kg of tea picked at baseline (among persons working >= 10 days in a
month), and allowing for 20% loss to follow-up, a sample size of 160 persons (80 per group)
will be sufficient to detect a 10% greater increase in daily mean weight of tea picked in the
intervention group compared to the control group (primary outcome). However, in order to have
sufficient data to conduct adequately powered analyses to compare the results for persons
aged 40 years and above, with those for persons aged at least 45 years and at least 50 years,
we will aim to recruit a total of 700 participants. These subgroup analyses will be important
for informing future policy, for example, if choices need to be made about which, if any, age
groups should be targeted for eyeglasses.
Statistical methods: The analysis of the primary outcome (as defined above) between
randomised groups will be done with and without adjustment for potential determinants of
productivity at baseline (including age and sex) and during the evaluation period (including
self-reported use of glasses in the intervention group and self-reported purchase and use of
glasses among the control group). The mean daily data for participants working <10 days in a
month during the evaluation period will be excluded from the main analyses in sensitivity
analyses to assess the impact of these workers on the overall results (both in relation to
the effect estimate and its confidence interval). Main analysis will also include
age-stratified analysis of participants (for example, 40-44, 45-49, 50-59, and 60 and above).
Study Roles and Monitoring: The principal investigator will be responsible for final approval
of the study protocol, overall study coordination and completing the UK ethical review. The
principal investigator has a long-standing working relationship with VisionSpring (VS) and
extensive experience in design and execution of randomised trials on a refractive error in
settings of limited resources. The principal investigator will visit India on two occasions:
During the Study Preparation period and at the time of the Baseline examination. The VS India
team will be responsible for coordinating fieldwork. VS has worked in India for 10 years, and
with APPL since 2014, and has extensive experience in carrying out presbyopic screening and
provision of near spectacles in India and a wide variety of LMIC settings. APPL will provide
support for the baseline examination, administration of the intervention and the end line
distribution of glasses to the Control Group. APPL will also be primarily responsible for the
collection of the primary study outcome (mean daily weight of picked tea) and the secondary
outcome of the quality of picked tea in both groups.
Dissemination strategy: The project management team will prepare a dissemination strategy
which balances the requirements of academic audiences (peer-reviewed journal publications and
conference presentations) with those of policy-makers and local patients and practitioners in
both the UK and India and our NGO partners. In submitting findings to a range of academic
journals, the investigators will focus on internationally-recognized journals with high
impact, particularly those such as BMJ and Lancet Global Health with open access policies,
making the papers more available to researchers and policy-makers in LMICs. The investigators
will collaborate with the Cochrane Eyes and Vision group to help them update reviews on the
economic impact of the correction of refractive error. At the conclusion of the main trial,
principal results will be available in English and several Indian languages and in graphic
format on a mobile-friendly project website. Results will also be shared through
organizations such as our Indian research partners and various locally-active eye health
NGOs.
Funding: Primary funding provided by Clearly (Clearly.World), free glasses provided by
VisionSpring (VisionSpring.org).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05326607 -
Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia
|
N/A | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Completed |
NCT05495971 -
Extended Depth of Focus Contact Lenses for Presbyopia
|
N/A | |
Completed |
NCT05464732 -
Vivity IOL: Emmetropia Compared to Monovision.
|
N/A | |
Recruiting |
NCT06045299 -
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
|
Phase 3 | |
Active, not recruiting |
NCT04151550 -
Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines)
|
N/A | |
Not yet recruiting |
NCT05506553 -
Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision
|
N/A | |
Completed |
NCT02554396 -
Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
|
Phase 2 | |
Completed |
NCT02214797 -
Dispensing Study to Assess Visual Performance of Prototype Contact Lenses
|
N/A | |
Completed |
NCT02235831 -
DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
|
N/A | |
Enrolling by invitation |
NCT01443585 -
Clinical Evaluation of a Progressive Addition Lens (PAL)
|
N/A | |
Completed |
NCT01591499 -
Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal
|
N/A | |
Completed |
NCT04983589 -
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
|
Phase 3 | |
Completed |
NCT02740010 -
The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
|
||
Recruiting |
NCT05796453 -
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
|
N/A | |
Completed |
NCT02516306 -
A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia
|
Phase 1/Phase 2 | |
Completed |
NCT05359380 -
The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
|
||
Not yet recruiting |
NCT04522427 -
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery
|
N/A | |
Completed |
NCT03688425 -
Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes
|
N/A | |
Recruiting |
NCT06053463 -
Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers
|
N/A |